GOVX (GeoVax Labs, Inc.) Forward P/E Multiple

Corporate company logo of GeoVax Labs Inc (GOVX)

The lack of profitability and reliance on grants directly limit the pricing power of GeoVax Labs, Inc. (GOVX) until FDA approval is secured. The trend of the company's forward P/E ratio clearly demonstrates this risk, where the 0.00 metric indicates the status of market expectations regarding payback. However, immunotherapy patents and virus-like particle developments establish a solid foundation for the future commercialization of medical discoveries.

Projected Price to Earnings: GeoVax (GOVX) for 07/04/2022 - 11/16/2026

Analytical breakdowns for GeoVax Labs, Inc.

- current price and projected stock value:
- business market valuation indicators:
Summary company analytics:geovax.com
Product sample of GeoVax Labs, Inc.

The high scalability of GeoVax Labs (GOVX) biopharmaceutical developments allows for the minimization of costs during global production following patent approval. The ratio of the current share price to expected cash flows reflects market expectations for future earnings; therefore, changes in the company's forward P/E ratio help investors timely identify asset overvaluation or the risk of business degradation amid technological shifts.

Competitors of GeoVax Labs, Inc. (GOVX)

Projected Price to Earnings ARGX (Argenx)|BNTX (BioNTech Group) - Future Price to Earnings Multiple|Forward P/E Multiple ABVX (Abivax SA)|Market Cap to Projected Earnings admabiologics.com (ADMA)|PTGX - Future Price to Earnings|Immunovant Inc (IMVT) - Projected Price to Earnings|Kiniksa Corp (KNSA) - Future Price to Earnings|Projected Price to Earnings Grifols, S.A.|Projected Price to Earnings ADPT|Forward P/E Multiple celldex.com|Future Price to Earnings Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Price to Future Earnings Ratio|Forward P/E Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Projected Price to Earnings Ratio|PHVS - Future Price to Earnings|ABCL - Forward P/E Multiple|Tourmaline (TRML) - Future Price to Earnings|Precigen - Future Price to Earnings Multiple|PHAR (Pharming Group NV) - Forward P/E Multiple|Forward P/E Multiple Nektar Therapeutics|Future Price to Earnings Upstream Bio Inc (UPB)|Forward P/E Multiple zenasbio.com (ZBIO)|Future Price to Earnings Immunome Corp IMNM|Forward P/E Multiple Gossamer Bio Inc GOSS|KALV - Future Price to Earnings|Future Price to Earnings Multiple SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Projected Price to Earnings|Savara Inc. - Future Price to Earnings Multiple|RIGL (Rigel Pharmaceuticals, Inc.) - Forward P/E Multiple|Future Price to Earnings ANAB|Forward P/E Multiple ATXS|ENGN - Projected Price to Earnings Ratio|Forward P/E Multiple RAPT (rapt.com)|Market Cap to Future Earnings Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forward P/E Multiple|Projected Price to Earnings Ratio Kyverna Therapeutics Inc.|TLSA: Forward P/E Multiple|CABA - Market Cap to Projected Earnings|VTYX (ventyxbio.com) - Forward P/E Multiple|Projected Price to Earnings Ratio Theratechnologies Inc. THTX|Projected Price to Earnings AVTX (avalotx.com)|Projected Price to Earnings Eledon Pharmaceuticals, Inc. ELDN|Future Price to Earnings Agenus, Inc AGEN|Climb Bio Inc - Future Price to Earnings|Zura Bio Limited - Forward P/E Multiple|Market Cap to Projected Earnings aTyr Pharma, Inc. ATYR|ADAG: Forward P/E Multiple|Price to Expected Earnings Ratio IMA (ImageneBio)|Projected Price to Earnings STTK|EQ: Future Price to Earnings Multiple|Future Price to Earnings Connect Pharma (CNTB)|Forward P/E Multiple Immunic Therapeutics (IMUX)|Forward P/E Multiple ATRA (Atara Biotherapeutics)|Future Price to Earnings Multiple IFRX|XFOR (X4 Pharma) - Projected Price to Earnings Ratio|Future Price to Earnings Multiple ACET (adicetbio.com)|CELU: Forward P/E Multiple|inmunebio.com (INMB) - Forward P/E Multiple|BRNS (Barinthus Biotherapeutics PLC) - Forward P/E Multiple|KZR: Future Price to Earnings Multiple|Future Price to Earnings SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Future Price to Earnings Multiple|Future Price to Earnings Enlivex Therapeutics Ltd ENLV|QTTB - Projected Price to Earnings|EDSA - Future Price to Earnings|Projected Price to Earnings Ratio iBio|CARM: Forward P/E Multiple|Price to Expected Earnings Ratio XTLB (XTL Biopharmaceuticals, Ltd.)|Future Price to Earnings boltbio.com|Forward P/E Multiple HCW Biologics|Forward P/E Multiple APVO|AIM - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt Inc.)|Market Cap to Projected Earnings GRI Bio, Inc. (GRI)|XRTX - Future Price to Earnings|reshapelifesciences.com (HIND) - Projected Price to Earnings|REVB: Forward P/E Multiple|Indaptus Therapeutics, Inc. - Future Price to Earnings Multiple|Future Price to Earnings Scinai|Projected Price to Earnings Ratio CalciMedica, Inc. CALI|Future Price to Earnings Affimed NV (AFMD)|Forward P/E Multiple Allakos Inc (ALLK)|Future Price to Earnings hookipapharma.com HOOK|Forward P/E Multiple IGM Biosciences, Inc. IGMS|iTeos Pharma - Forward P/E Multiple|OCEA - Forward P/E Multiple|TCBP: Forward P/E Multiple|Third Harmonic Bio - Future Price to Earnings Multiple